CeriBell, Inc. Common Stock (CBLL)

• Market cap: $581M
• 1 day: 5.75%
• 5 days: 6.94%
• 1 month: -16.80%
• 3 months: -30.60%
• 6 months: -37.63%
• Year to date: -37.39%
• 1 year: -35.24%
• 5 years: -35.24%
• 10 years: -35.24%
• Sector: Healthcare
• Industry: Medical Devices

About: CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Employees: 281

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

64.46% more ownership

Funds ownership: 0% [Q3] → 64.46% (+64.46%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $32 98% upside
• Avg. target: $33 101% upside
• High target: $33 104% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Ladenburg Thalmann Jeff Cohen 25% 1-year accuracy 1 / 4 met price target	98% upside $32	Buy Initiated	4 Apr 2025
Canaccord Genuity William Plovanic 40% 1-year accuracy 19 / 48 met price target	104% upside $33	Buy Maintained	26 Feb 2025